Critical noise level reduction for correct identification of late potentials: An illustrative case report

1991 ◽  
Vol 14 (9) ◽  
pp. 779-781 ◽  
Author(s):  
Piotr Kulakowski ◽  
Francis D. Murgatroyd ◽  
A. John Camm
Disabilities ◽  
2021 ◽  
Vol 1 (1) ◽  
pp. 1-22
Author(s):  
Roslyn Livingstone ◽  
Ginny Paleg

Recent advances in medical interventions have changed the prognosis for children with infantile-onset spinal muscular atrophy (SMA-1); however, little has been published regarding rehabilitation management. A rapid scoping review was conducted in November 2020 using Medline and CINAHL databases. Evidence supporting use of assistive devices and equipment to enhance participation, mobility, function, and posture in lying, sitting, and standing positions was sought. From 239 articles, only five studies (describing use of augmentative communication, manual and power mobility, supported standing and orthotic devices) met inclusion criteria. Results are presented alongside a case report of a 5-year-old boy (treated with Nusinersen since 7 months-of-age) who uses a variety of devices to enhance his activity and participation in family life. While reclined and tilted sitting positions as well as power mobility were previously considered for children with SMA-1, this child has progressed to supported upright standing, self-propelling a lightweight manual wheelchair indoors, communicating using multiple methods and taking steps in a dynamic mobility device. Power mobility was introduced in a switch-adapted cart at 11 months and he was independently exploring indoors and outside in his power wheelchair before 20 months. Research evidence is limited, but alongside the case report highlights the importance of a comprehensive and proactive approach to enhancing function, fun and participation with family and friends through adaptive equipment for children with significant and life-limiting disabilities.


2007 ◽  
Vol 43 (6) ◽  
pp. 526-530 ◽  
Author(s):  
Marcus C. Korinth ◽  
Alexandra Kapser ◽  
Martin R. Weinzierl

2018 ◽  
Vol 5 ◽  
Author(s):  
Ma. G. Aguilera-Arreola ◽  
Martha L. Ostria-Hernández ◽  
Enrique Albarrán-Fernández ◽  
Sara R. Juárez-Enriquez ◽  
Cristina Majalca-Martínez ◽  
...  

2011 ◽  
Vol 17 (7) ◽  
Author(s):  
Nuno Menezes ◽  
Guedes Rita ◽  
Leite Inês ◽  
Varela Paulo ◽  
Baptista Armando

2020 ◽  
Author(s):  
Alice Serafini ◽  
Peter K. Kurotschka ◽  
Mariabeatrice Bertolani ◽  
Silvia Riccomi

Abstract Background: the most commonly reported clinical manifestations of Coronavirus Disease (COVID- 19) are: fever, fatigue, dry cough, anorexia, myalgias, dyspnoea and sputum production. Other, rarer, manifestations include headache, sore throat, rhinorrhoea, nausea, diarrhoea and olfactory or taste disorders. Two recent small-scale studies suggest the possibility of a skin rash being a clinical presentation of the disease. The purpose of our case report is to bring attention to an atypical presentation of the disease (skin rash) and reflect on the importance of the correct identification of COVID-19 suspicious symptoms as part of the crucial activity of case-finding in primary care.Case presentation: the patient is an Italian 32 years old female nurse who has had several close contacts to COVID-19 cases during her working shifts. On the 13 th March 2020 she developed an itchy erythematous papular rash sparing only her sparing only her face, scalp and abdomen. One week later she developed fever and diarrhoea. During the first week of remote assessment carried out by her General Practitioner (GP), she gradually developed a dry cough, intermittent fever and diarrhoea. At the time of article submission (31 days after the symptoms onset), she has not completely recovered and is still suffering of a dry cough, headache, fatigue and, occasionally, diarrhoea.Conclusions: this study suggest that skin manifestations could be an early presentation of COVID-19 and, during outbreaks, they should be taken into proper account by primary care providers as possibly caused by Sars-Cov-2. Early identification of COVID-19 patients is a crucial part of the strategy of case detection and case isolation, which has shown to be crucial in the reduction of incidence and COVID-19-related mortality. Further research is needed to establish frequency, symptoms, signs, pathogenesis and role in case detection of skin manifestations in COVID-19 patients.


Sign in / Sign up

Export Citation Format

Share Document